Jason B. Shandell, President and General Counsel at Amphastar Pharmaceuticals, Inc. (AMPH), sold 700 shares at $20.45 ($14K) on 2018-03-13, disclosed to the SEC on 2018-03-15.
Scheduled sale ($14k) by President and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.45 | 300 | $6K | 42.9% |
| 2 | $20.45 | 400 | $8K | 57.1% |
| Total | $20.45 avg | 700 | $14K | 100% |
| Filing → |
| AMPH | SELL | 2019-12-20 | $314K | — | Filing → |
| AMPH | SELL | 2019-09-20 | $313K | — | Filing → |
| AMPH | SELL | 2019-07-12 | $269K | — | Filing → |